Osimertinib in NSCLC With Atypical EGFR-Activating Mutations: A Retrospective Multicenter Study
Titel:
Osimertinib in NSCLC With Atypical EGFR-Activating Mutations: A Retrospective Multicenter Study
Auteur:
Ji, Jingran Aredo, Jacqueline V. Piper-Vallillo, Andrew Huppert, Laura Rotow, Julia K. Husain, Hatim Stewart, Susan Cobb, Rosemary Wakelee, Heather A. Blakely, Collin M. Wong, Melisa L. Gubens, Matthew A. Madani, Mohammad H. Digumarthy, Subba R. McCoach, Caroline Piotrowska, Zofia Neal, Joel W. Riess, Jonathan W.